Intelligence Β· Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs Β· EMA approved Β· by data quality Β· Page 15 of 39

  1. elranatamab

    ELREXFIO Pfizer Australia Pty Ltd

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved

  2. elvitegravir

    GENVOYA

    ORAL FDA: approved Β· EMA: approved

    J05AR
  3. emicizumab

    HEMLIBRA

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    B02BX06
  4. empagliflozin

    JARDIANCE Boehringer Ingelheim Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    A10BD19
  5. encorafenib

    BRAFTOVI Pierre Fabre Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L01EC03
  6. enfuvirtide

    FUZEON

    SUBCUTANEOUS FDA: approved Β· EMA: approved

    J05AX07
  7. entrectinib

    ROZLYTREK Hoffmann-La Roche

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L01EX14
  8. enzalutamide

    XTANDI Astellas Pharma Inc

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L02BB04
  9. epoetin alfa

    EPOSTIM

    SINGLE-USE FDA: approved Β· EMA: approved

    B03XA01
  10. erdafitinib

    BALVERSA

    ORAL FDA: approved Β· EMA: approved

    L01EN01
  11. ertugliflozin

    SEGLUROMET

    ORAL FDA: approved Β· EMA: approved

    A10BK04
  12. etanercept

    BRENZYS Pfizer Australia Pty Ltd

    SUBCUTANEOUS FDA: approved Β· EMA: approved Β· TGA: approved

    L04AB01
  13. etelcalcetide

    PARSABIV

    INTRAVENOUS FDA: approved Β· EMA: approved Β· NMPA: clinical trials

    H05BX04
  14. evolocumab

    REPATHA Amgen

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    C10AX13
  15. fenfluramine

    FINTEPLA

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    N03
  16. fentanyl

    ABSTRAL Apotex Pty Ltd

    BUCCAL FDA: approved Β· EMA: approved Β· TGA: approved

    N02AB03
  17. ferric maltol

    FERACCRU

    ORAL FDA: approved Β· EMA: approved

    B03AB
  18. fezolinetant

    VEOZA

    ORAL FDA: approved Β· EMA: approved

    G02CX06
  19. fidaxomicin

    DIFICLIR

    ORAL FDA: approved Β· EMA: approved

    A07AA12
  20. finerenone

    KERENDIA Bayer Australia Ltd

    FILM COATED FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    C09
  21. fingolimod

    AKM FINGOLIMOD Alphapharm Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L04AA27
  22. fluticasone furoate

    ARNUITY ELLIPTA GlaxoSmithKline

    NASAL FDA: approved Β· EMA: approved Β· TGA: approved

    R03AL08
  23. futibatinib

    LYTGOBI

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved

    L01EN04
  24. gadopiclenol

    ELUCIREM

    INTRAVENOUS FDA: approved Β· EMA: approved

    V08CA12

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.